GLP-1 receptors are expressed in brain regions involved in mood regulation, making a theoretical psychiatric effect biologically plausible but unconfirmed for retatrutide
Novo Nordisk, the company that makes the drugs, reportedthat in 2022, 81% of Wegovypatients were women
An increased risk of adverse effects to the fetus has been shown in women who took Zofran, especially during the first trimester of pregnancy
But Dr Alvin Mondoh, a Kenyan weight-management specialist, says "people still do need help" through medical intervention, as weight gain can be caused "by factors beyond your control"
Even if a patient is not obtaining GLP-1s directly from an on-line compounding pharmacy, the question remains as to where the patients direct supplier obtained the medication
At the centre of this transformation are GLP-1 receptor agonists, hailed in headlines as wonder drugs and everything drugs